MYC and ovarian carcinoma: Using ovarian cancer cell models, we revealed that the upregulated PITX2 could elevate cell cycle regulators such as CyclinD1 and C-myc, and promote cell proliferation, cell migration/invasion as well as tumor growth in xenograft model mice.